Clinical Trial Update: The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing PK interactions when co-administering metformin sustained-release, rosuvastatin, and JLP-1310 in healthy male volunteers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperlipidemia

Drugs mentioned

• JLP-1310
• Metformin SR (metformin)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Diabetes, Hyperlipidemia | Phase 1 | Status: COMPLETED